NCT04080765
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Johns Hopkins School of Medicine Baltimore, Maryland, United States
Clinical trial condition
Blood-Borne Infections
Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.
8,276 public trials
443 recruiting studies
Blood-Borne Infections trial results
NCT01198418
- Conditions
- Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- University of California, San Diego San Diego, California, United States
- University of California, Los Angeles (Harbor) Torrance, California, United States
Completed
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
NCT00006164
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +20 more
- Locations
-
- University of California-Irvine/VA Medical Center-Long Beach Long Beach, California, United States
- USC School of Medicine Los Angeles, California, United States
- UCHSC (University of Colorado) Denver, Colorado, United States
- University of Connecticut Health Center Farmington, Connecticut, United States
NCT04382339
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
Not specified
NCT03100643
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
NCT01550341
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +21 more
- Locations
-
- Howard University Washington D.C., District of Columbia, United States
NCT03324009
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cervical Cancer, +26 more
- Locations
-
- Princess Marina Hospital Gaborone, Botswana
Completed
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
NCT01944371
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- San Francisco General Hospital San Francisco, California, United States
- Alfred Hospital Melbourne, Australia
Completed
Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection
NCT04019717
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
- Locations
-
- Clinical Trial Site Antwerp, Belgium
- Clinical Trial Site Phoenix, Mauritius
- Clinical Trial Site Chisinau, Moldova
NCT04372667
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- Elizabeth Glaser Pediatric AIDS Foundation Lilongwe, Malawi